Johnson Chemical Pharmaceutical Works Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was TWD 606.71 million compared to TWD 494.67 million a year ago. Net income was TWD 79.7 million compared to TWD 64.85 million a year ago.

Basic earnings per share from continuing operations was TWD 2.24 compared to TWD 2.16 a year ago. Diluted earnings per share from continuing operations was TWD 2.18 compared to TWD 2.16 a year ago.